Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer

NCT01727076 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

NIH

Sponsor class

Conditions

Head and Neck Squamous Cell Carcinoma
Recurrent Head and Neck Carcinoma
Recurrent Non-Small Cell Lung Carcinoma
Recurrent Renal Cell Carcinoma
Recurrent Skin Carcinoma
Stage III Renal Cell Cancer
Stage IIIA Cutaneous Melanoma AJCC v7
Stage IIIA Non-Small Cell Lung Cancer AJCC v7
Stage IIIB Cutaneous Melanoma AJCC v7
Stage IIIB Non-Small Cell Lung Cancer AJCC v7
Stage IIIC Cutaneous Melanoma AJCC v7
Stage IV Cutaneous Melanoma AJCC v6 and v7
Stage IV Non-Small Cell Lung Cancer AJCC v7
Stage IV Renal Cell Cancer

Interventions

OTHER: Laboratory Biomarker Analysis
OTHER: Pharmacological Study
BIOLOGICAL: Recombinant Human Interleukin-15

Sponsor

National Cancer Institute (NCI)